- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 671800 ED placebo
Total 412 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthy VolunteersGermany
-
Boehringer IngelheimCompletedHealthyJapan, Korea, Republic of
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimTerminatedCystic FibrosisUnited States, Spain, Belgium, Germany, Canada, United Kingdom, Sweden, France
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimWithdrawnHIV Infections | Healthy
-
Boehringer IngelheimCompletedSchizophreniaUnited States, Taiwan, Germany, Japan, Canada
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Argentina, Australia, Austria, Canada, Czech Republic, France, Germany, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Switzerland, United Kingdom
-
Boehringer IngelheimCompletedDermatitis, AtopicUnited States, Japan, Canada
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Germany, Spain, Taiwan, Hungary, Poland, Korea, Republic of, Austria, New Zealand, United Kingdom, Czechia, Puerto Rico
-
Boehringer IngelheimCompleted
-
AbbVieBoehringer IngelheimCompletedAsthmaUnited States, Korea, Republic of, Belgium, Taiwan, Canada, Germany, United Kingdom, France, Netherlands, Poland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey
-
Boehringer IngelheimCompletedGeneralized Pustular PsoriasisUnited States, Singapore, Korea, Republic of, Germany, Japan, Malaysia, China, France, Thailand, Tunisia, Switzerland, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
Presidio Pharmaceuticals, Inc.Boehringer IngelheimCompletedChronic Hepatitis CUnited States
-
Boehringer IngelheimActive, not recruitingSchizophreniaUnited States, United Kingdom, Taiwan, Germany, Bulgaria, Mexico, Argentina, Denmark, Korea, Republic of, Austria, China, Belgium, Czechia, Finland, Serbia, Brazil, Portugal, Lithuania
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
Boehringer IngelheimCompletedColitis, UlcerativeUnited Kingdom, Denmark, Germany, Spain, Netherlands, Norway
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthyKorea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedSchizophreniaUnited States, United Kingdom, Australia, Canada, France, New Zealand
-
Boehringer IngelheimTerminatedCOVID-19United States, Spain
-
AbcentraCompletedA Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk FactorsCoronary Artery Disease | Inflammation | Psoriasis | Cardiometabolic SyndromeUnited States
-
Boehringer IngelheimActive, not recruitingCrohn DiseaseUnited States, Belgium, Germany, Hungary, Spain, United Kingdom, Denmark, Czechia, Poland, Italy, Netherlands
-
Boehringer IngelheimCompletedKidney Disease, ChronicUnited States, Spain, Korea, Republic of, Belgium, Australia, Hong Kong, India, Canada, China, Germany, Italy, Japan, Malaysia, Finland, Switzerland, Turkey, Hungary, Poland, Portugal, Philippines, Czechia, Greece, Bulgaria, Brazil, Arg... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, Austria, Canada, France, Germany
-
AbbVieActive, not recruitingPsoriatic ArthritisUnited States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Estonia, Finland, Germany, Greece, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico and more
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Belgium, Canada, Germany, Russian Federation
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Boehringer IngelheimCompletedHepatitis CAustria, Belgium, France, Germany, Japan, Portugal, Romania, Russian Federation, Spain, Switzerland, United Kingdom